Canopy Growth Corporation

WEED

CA1380357048

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 04:18:04 2024-05-17 pm EDT			5-day change	1st Jan Change
14.81 ^CAD	-1.07%		+19.82%	+119.08%

May. 16	Pot stocks rise as US unveils proposal to ease restrictions on marijuana	RE
May. 16	US Government Reclassifies Marijuana to Less-Restrictive Category	MT

Canopy Growth Corporation exercised its option to acquire 75% interest in Jetty Extracts.

May 06, 2024

Canopy Growth Corporation (TSX:WEED) exercised its option to acquire 75% interest in Jetty Extracts on May 7, 2024. Transaction is subject to certain customary closing conditions, including receipt of regulatory approvals.

Latest news about Canopy Growth Corporation

Pot stocks rise as US unveils proposal to ease restrictions on marijuana	May. 16	RE
US Government Reclassifies Marijuana to Less-Restrictive Category	May. 16	MT
Canopy Growth, Tilray Shares Rise After DOJ Proposes Marijuana Reclassification	May. 16	DJ
Justice Department Set to Post Cannabis Reclassification Plans	May. 16	MT
Investors wary of US cannabis ETFs despite recent rally	May. 07	RE
Canopy USA Exercises Options to Acquire Wana, Jetty	May. 07	MT
Canopy Growth Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty	May. 07	MT
Canopy Growth Brief: Confirming Canopy USA's Exercise of Options to Acquire Wana and Jetty	May. 07	MT
Canopy Growth Corporation exercised its option to acquire Wana Brands for $300 million.	May. 06	CI
Canopy Growth Corporation exercised its option to acquire 75% interest in Jetty Extracts.	May. 06	CI
Canopy Growth to Get $50 Million in Proceeds From Debt Accord	May. 03	MT
Canopy Growth Secures US$50 Million in Financing	May. 03	MT
Canopy Growth Brief: C$27.5 Millon of Debt Extended from 2025 to 2029	May. 03	MT
Canopy Growth Brief: Announcing Financing to Further Strengthen Balance Sheet Including Approximately US$50 Million of New Gross Proceeds	May. 03	MT
Canopy Growth Corporation announced that it expects to receive CAD 27.5 million in funding	May. 01	CI
TSX Closer: Market Manages a Small Gain as Focus on US Interest-Rate Decision, Powell Comments	May. 01	MT
TSX Down 55 Points at Midday With Healthcare/Cannabis Stocks Posting The Biggest Declines	May. 01	MT
Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Wednesday; Starbucks, Super Micro Computer to Decline	May. 01	MT
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	Apr. 30	DJ
Sector Update: Consumer Stocks Slipping in Late Afternoon Trading	Apr. 30	MT
Cannabis Stocks Jump on Report DEA to Reclassify Marijuana as Less Dangerous Drug	Apr. 30	MT
Cannabis Stocks Rise on Media Report of DEA Reclassifying Marijuana as Less Dangerous Drug	Apr. 30	MT
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug	Apr. 30	RE
Canopy Growth Slides After Constellation Directors Leave, Share Conversion	Apr. 18	DJ
Stocks to Watch : Canopy Growth, Metropolitan Bank, Netflix	Apr. 18	DJ

Chart Canopy Growth Corporation

Duration

Period

More charts

Company Profile

Canopy Growth Corporation is a cannabis and consumer packaged goods (CPG) company. The Company delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space. Its CPG portfolio includes gourmet wellness products by Martha Stewart CBD, and vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution, and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a diverse range of cannabis, hemp, and cannabis products in Canada. Its Rest-of-world cannabis segment includes the production, distribution, and sale of a diverse range of cannabis and hemp products internationally. Its Storz & Bickel segment includes the production, distribution, and sale of vaporizers.

Sector

Pharmaceuticals

Calendar

2024-05-29 - Q4 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Canopy Growth Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

14.81 CAD

Average target price

7.808 CAD

Spread / Average Target

-47.28%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Alternative Medicine

	1st Jan change	Capi.
CANOPY GROWTH CORPORATION	+119.08%	817M
DONG-E-E-JIAO CO.,LTD.	+42.38%	6.26B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-15.86%	4.49B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+6.36%	3.29B
TASLY PHARMACEUTICAL GROUP CO., LTD	-11.28%	3.12B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-3.23%	2.5B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+45.24%	1.94B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD.	-7.89%	1.68B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	-0.98%	1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD	-11.32%	1.56B

Alternative Medicine